Literature DB >> 11884460

HIV-1 down-modulates gamma signaling chain of Fc gamma R in human macrophages: a possible mechanism for inhibition of phagocytosis.

Katherine Kedzierska1, Philip Ellery, Johnson Mak, Sharon R Lewin, Suzanne M Crowe, Anthony Jaworowski.   

Abstract

HIV-1 infection impairs a number of macrophage effector functions, thereby contributing to development of opportunistic infections and the pathogenesis of AIDS. FcgammaR-mediated phagocytosis by human monocyte-derived macrophages (MDM) is inhibited by HIV-1 infection in vitro, and the underlying mechanism was investigated in this study. Inhibition of phagocytosis directly correlated with the multiplicity of HIV-1 infection. Expression of surface FcgammaRs was unaffected by HIV-1 infection, suggesting that inhibition of phagocytosis occurred during or after receptor binding. HIV-1 infection of MDM markedly inhibited tyrosine phosphorylation of the cellular proteins, which occurs following engagement of FcgammaRs, suggesting a defect downstream of initial receptor activation. FcgammaR-mediated phagocytosis in HIV-infected MDM was associated with inhibition of phosphorylation of tyrosine kinases from two different families, Hck and Syk, defective formation of Syk complexes with other tyrosine-phosphorylated proteins, and inhibition of paxillin activation. Down-modulation of protein expression but not mRNA of the gamma signaling subunit of FcgammaR (a docking site for Syk) was observed in HIV-infected MDM. Infection of MDM with a construct of HIV-1 in which nef was replaced with the gene for the gamma signaling subunit augmented FcgammaR-mediated phagocytosis, suggesting that down-modulation of gamma-chain protein expression in HIV-infected MDM caused the defective FcgammaR-mediated signaling and impairment of phagocytosis. This study is the first to demonstrate a specific alteration in phagocytosis signal transduction pathway, which provides a mechanism for the observed impaired FcgammaR-mediated phagocytosis in HIV-infected macrophages and contributes to the understanding of how HIV-1 impairs cell-mediated immunity leading to HIV-1 disease progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884460     DOI: 10.4049/jimmunol.168.6.2895

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy.

Authors:  C Michailidis; G Giannopoulos; V Vigklis; K Armenis; A Tsakris; P Gargalianos
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 2.  Phagocytic activity in human immunodeficiency virus type 1 infection.

Authors:  Agostino Pugliese; Valerio Vidotto; Tiziana Beltramo; Donato Torre
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

3.  Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.

Authors:  Edwin Leeansyah; Anupama Ganesh; Máire F Quigley; Anders Sönnerborg; Jan Andersson; Peter W Hunt; Ma Somsouk; Steven G Deeks; Jeffrey N Martin; Markus Moll; Barbara L Shacklett; Johan K Sandberg
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

4.  Decreased Fc receptor expression on innate immune cells is associated with impaired antibody-mediated cellular phagocytic activity in chronically HIV-1 infected individuals.

Authors:  Anne-Sophie Dugast; Andrew Tonelli; Christoph T Berger; Margaret E Ackerman; Gaia Sciaranghella; Qingquan Liu; Magdalena Sips; Ildiko Toth; Alicja Piechocka-Trocha; Musie Ghebremichael; Galit Alter
Journal:  Virology       Date:  2011-05-12       Impact factor: 3.616

5.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

6.  Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study.

Authors:  Edwin Leeansyah; Jingling Zhou; Geza Paukovics; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

7.  Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.

Authors:  Rahul Mittal; Sunil K Sukumaran; Suresh K Selvaraj; David G Wooster; M Madan Babu; Alan D Schreiber; J Sjef Verbeek; Nemani V Prasadarao
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

8.  Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages.

Authors:  Clare L V Westhorpe; Jingling Zhou; Nicole L Webster; Bill Kalionis; Sharon R Lewin; Anthony Jaworowski; William A Muller; Suzanne M Crowe
Journal:  J Leukoc Biol       Date:  2009-06       Impact factor: 4.962

Review 9.  Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Authors:  Margaret E Ackerman; Galit Alter
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

Review 10.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.